Sarah Cannon Research Partner
Research Partner with SCRI
In June 2011, The Tampa Bay Heart Institute at Northside Hospital partnered with Sarah Cannon Research Institute (SCRI), one of the largest global clinical research programs. This partnership designates TBHI as a cardiovascular clinical research strategic site.
SCRI’s rapidly expanding cardiovascular research network enables hospitals and physician practices to develop their research programs and provides the opportunity for patients to consider participation in clinical trials in their own community.
The benefits of this relationship are far-reaching for Northside patients and their families. Together, we will now be able to provide patients with:
- Expanded treatment options -- improved local access to clinical trials and leading-edge treatments that can be administered close to home;
- Consistent care -- an increased ability to retain continuity of care with physicians they know and trust; and
- Innovative medicine -- the ability to participate in investigator-initiated trials with promising drug combination therapies.
As part of the agreement, SCRI will help manage industry sponsored and investigator initiated clinical trials in interventional cardiology and electrophysiology. In addition, the staff will have access to SCRI’s physician experts and clinical research team.